Acquired Immunodeficiency Syndrome: all 3,037 studies
Page 20 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.
- Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost (Kenya)CompletedNCT01645865
- Addressing Proven Factors in HIV Prevention for Latino YouthStatus unknownNCT01633879Phase 2/3
- Evaluation of the Bioequivalence of a Combined Formulated TabletCompletedNCT01622790Phase 1
- A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted ConditionsCompletedNCT01619527Phase 1
- Minority AIDS Initiative Retention and Re-Engagement ProjectCompletedNCT01616940Not applicable
- Fetal HIV Transmission Risk and Duration of Membrane RuptureCompletedNCT01616823
- An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected PatientsCompletedNCT01615601
- Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine UsersCompletedNCT01614106Not applicable
- Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic SuppressionCompletedNCT01613157
- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug UsersCompletedNCT01612169Not applicable
- Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIVCompletedNCT01607541Phase 2/3
- Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir MonotherapyCompletedNCT01606722
- Atazanavir/r + Lamivudine Dual TherapyCompletedNCT01599364Phase 4
- International HIV Antiretroviral Adherence, Resistance and SurvivalCompletedNCT01596322
- Safety,Effectiveness and Acceptability of Sino-implant II in DRCompletedNCT01594632Not applicable
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult SubjectsCompletedNCT01593046Phase 1
- The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in LesothoStatus unknownNCT01589965Early Phase 1
- The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
- Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once DailyCompletedNCT01581853Phase 4
- Positively Smoke Free on the Web (PSFW) for Smokers Living With HIVCompletedNCT01570595Phase 1/2
- A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).CompletedNCT01563328Phase 1
- An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAARTCompletedNCT01541085
- Dolutegravir Expanded Access StudyCompletedNCT01536873Not applicable
- Operational Research for Cryptococcal Antigen ScreeningCompletedNCT01535469Phase 4
- Methadone Maintenance and HIV Prevention: A Window of Opportunity in ChinaCompletedNCT01532609Not applicable
- Inflammation, Viral Replication, and Atherosclerosis in Treated HIV InfectionCompletedNCT01519141
- A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of DigoxinCompletedNCT01519128Phase 1
- Pilot Feasibility Trial of the Family Strengthening Intervention in Rwanda (FSI-R)CompletedNCT01509573Not applicable
- Rapid Oral Test for Therapeutic Response in HIV/AIDS PatientsCompletedNCT01507142
- Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)CompletedNCT01502618Not applicable
- Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older AdultsCompletedNCT01499706Phase 1
- Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and EthinylestradiolCompletedNCT01498861Phase 1
- Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected VolunteersCompletedNCT01496989Phase 1
- Tissue Drug Levels of HIV MedicationsCompletedNCT01490346
- Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service OrganizationsCompletedNCT01482923
- Vitamin D Supplementation in HIVCompletedNCT01475890Phase 2/3
- Bioequivalence Study of Pediatric Formulations to Treat HIV InfectionStatus unknownNCT01469520Phase 1
- A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult SubjectsCompletedNCT01467531Phase 1
- Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.CompletedNCT01467518Phase 1
- A Prospective Observational Study of the Clinical Performance of Femplant in PakistanCompletedNCT01463254
- Obesity in HIV After Antiretroviral TherapyCompletedNCT01461876
- Problems With Immune Recovery in the Gut TissueCompletedNCT01460433
- Unboosted Atazanavir as Initial ART Therapy in ChinaCompletedNCT01459575
- Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural LesothoCompletedNCT01459120Not applicable
- A Commitment Device for Medication Adherence Among HIV PatientsCompletedNCT01455740Not applicable
- Video-Based Delivery of HIV Test Information for Spanish-Speaking LatinosStatus unknownNCT01452555Phase 3
- Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6CompletedNCT01452503Not applicable
- Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean SectionCompletedNCT01450059
- Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)CompletedNCT01448915
- Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingCompletedNCT01447680
- Bridges to the Future: Economic Empowerment for AIDS-Orphaned Children in UgandaCompletedNCT01447615Not applicable
- Dimiracetam in Painful Neuropathies Affecting AIDS PatientsStatus unknownNCT01444690Phase 2
- Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment TrialWithdrawnNCT01442428Phase 2/3
- Etravirine Plus 2 Analogs in HIV-infected PatientsCompletedNCT01437241
- Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment FailureStatus unknownNCT01433601Not applicable
- Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIVCompletedNCT01433185Not applicable
- Safety Study of Maraviroc's Effect on Human OsteoclastsCompletedNCT01428986
- Safety and Immunogenicity of HIVAX in HIV-1 Infected SubjectsStatus unknownNCT01428596Phase 1
- Drug Interaction Study Between Dolutegravir and PrednisoneCompletedNCT01425099Phase 1
- Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable
- HCV/HIV Coinfection: Antiviral Therapy and FibrosisCompletedNCT01423643
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected PatientsCompletedNCT01422330Phase 4
- Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With LipohypertrophyTerminatedNCT01420523Phase 2
- Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy AdultsCompletedNCT01418235Phase 1
- Adolescent Master ProtocolCompletedNCT01418014
- Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining EventsCompletedNCT01417949Phase 4
- Centralized Off-Site Adherence Enhancement ProgramCompletedNCT01409655Not applicable
- Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIVCompletedNCT01407237
- Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV CareCompletedNCT01406626Not applicable
- A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female SubjectsCompletedNCT01403792Phase 1
- Project RAP: Family-based HIV Prevention in the Juvenile Drug CourtCompletedNCT01403298Not applicable
- Stanford Universities: The Stanford HIV Aging CohortCompletedNCT01401348
- HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan YouthCompletedNCT01401335Not applicable
- Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected WomenCompletedNCT01385241Not applicable
- Relative Bioavailability Study of a Pediatric Granule Formulation of DolutegravirCompletedNCT01382238Phase 1
- Spatial Epidemiology of HIV InfectionCompletedNCT01377272
- HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment AdherenceCompletedNCT01369056Not applicable
- Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)TerminatedNCT01367210Phase 4
- Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination TabletsCompletedNCT01366547Phase 1
- A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIVCompletedNCT01362634Not applicable
- Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, IndonesiaCompletedNCT01360463Phase 2
- Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)CompletedNCT01359280Phase 1/2
- Dolutegravir Renal Impairment StudyCompletedNCT01353716Phase 1
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV InfectionCompletedNCT01350648
- Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023CompletedNCT01348516Phase 1
- Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected PatientsCompletedNCT01348308Phase 3
- Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.Status unknownNCT01344148Not applicable
- A Prospective Observational Study of the Performance of Zarin in KenyaCompletedNCT01334190
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese SubjectsCompletedNCT01332565Phase 1
- HIV and Drug Use in Georgian WomenCompletedNCT01331460Not applicable
- EuroSIDA As An External Comparator To MOTIVATE TrialsCompletedNCT01329783
- Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)CompletedNCT01327898Phase 2
- Rwanda Selenium Supplementation Clinical TrialCompletedNCT01327755Phase 3
- Managerial Database IICompletedNCT01322217
- The VMVN Study: Virological Monitoring in Viet NamCompletedNCT01317498Not applicable
- Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for TuberculosisStatus unknownNCT01315301Not applicable
- HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow TransplantationStatus unknownNCT01309594Not applicable
- Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance TherapyCompletedNCT01307488Phase 4
- Understanding Medication Adherence Among HIV PatientsCompletedNCT01305590Not applicable
- Internet-Based Sexual Health Education for Middle School Native American YouthCompletedNCT01303575Not applicable